Amgen Stock Forecast

Stock Price Forecast

According to 35 analysts polled by S&P Global, Amgen stock has a consensus rating of "Buy" and an average price target of $352.77. The average 1-year stock price forecast is 4.49% higher than the current stock price, while the lowest is $200 (-40.76%) and the highest is $427 (+26.48%).

Price Target: $352.77 (+4.49%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$200	$352.77	$352.5	$427
Change	-40.76%	+4.49%	+4.41%	+26.48%

Analyst Ratings

The average analyst rating for Amgen stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	10	9	9	9	10	10
Buy	4	4	4	4	4	4
Hold	15	17	18	19	18	18
Sell	1	1	1	1	1	1
Strong Sell	2	2	2	2	2	2
Total	32	33	34	35	35	35

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Salim Syed Mizuho Securities	Mizuho Securities	Hold Maintains $295 → $303	Hold	Maintains	$295 → $303	-10.25%	Jun 15, 2026
David Amsellem Piper Sandler	Piper Sandler	Buy Reiterates $427	Buy	Reiterates	$427	+26.48%	Jun 12, 2026
Terence Flynn Morgan Stanley	Morgan Stanley	Hold Maintains $332 → $340	Hold	Maintains	$332 → $340	+0.71%	Jun 10, 2026
Courtney Breen Bernstein	Bernstein	Hold Maintains n/a	Hold	Maintains	n/a	n/a	Jun 10, 2026
Salveen Richter Goldman Sachs	Goldman Sachs	Buy Maintains $425 → $389	Buy	Maintains	$425 → $389	+15.23%	Jun 5, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

37.78B

from 36.75B

2.80%

from 36.75B

Revenue Next Year

38.75B

from 37.78B

2.56%

from 37.78B

EPS This Year

22.39

from 21.84

2.51%

from 21.84

EPS Next Year

23.48

from 22.39

4.86%

from 22.39

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	25.98B	26.32B	28.19B	33.42B	36.75B	37.78B
Revenue Growth	2.18%	1.32%	7.09%	18.57%	9.95%	2.80%
Gross Profit	19.53B	19.95B	20.40B	22.97B	26.01B	31.05B
Gross Margin	75.16%	75.78%	72.35%	68.71%	70.78%	82.18%
Operating Income	9.15B	10.10B	9.82B	9.68B	11.57B	16.51B
Net Income	5.89B	6.55B	6.72B	4.09B	7.71B	8.26B
EPS	-	-	-	-	21.84	22.39
EPS Growth	-	-	-	-	10.08%	2.51%
Forward PE	13.06	14.40	14.95	12.59	15.46	15.08
Dividend / Share	7.04	7.76	8.52	9.00	9.52	10.09
Dividend Growth	-	10.23%	9.79%	5.63%	5.78%	5.96%
Free Cash Flow	7.52B	8.69B	3.39B	13.73B	7.50B	13.44B
No. Analysts	-	-	-	-	-	32

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	38.5B
Avg	37.8B
Low	37.1B

Revenue Growth

Revenue Growth	2026	2027	2028
High	4.6%
Avg	2.8%
Low	0.9%

EPS Forecast

EPS	2026	2027	2028
High	23.01
Avg	22.39
Low	21.70

EPS Growth

EPS Growth	2026	2027	2028
High	5.4%
Avg	2.5%
Low	-0.6%